How should we advise patients about the chemoprevention of prostate cancer?
BJU Int
.
2005 Aug;96(3):231-2.
doi: 10.1111/j.1464-410X.2005.05606.x.
Authors
Roger S Kirby
1
,
John M Fitzpatrick
Affiliation
1
St George's Hospital, London, UK. editor.bjuint@mater.ie
PMID:
16042705
DOI:
10.1111/j.1464-410X.2005.05606.x
No abstract available
MeSH terms
Chemoprevention
Humans
Male
Patient Education as Topic
Prostatic Neoplasms / prevention & control*